Inspire Medical Systems, Inc. to Report First Quarter 2021Financial Results on May 4, 2021

Download as PDF

MINNEAPOLIS – April 6, 2021 – Inspire Medical Systems, Inc. (NYSE: INSP)
(“Inspire”), a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea, today announced that it will release financial results for the first
quarter 2021 after the close of trading on Tuesday, May 4. Inspire’s management team
will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to
discuss the financial results and recent business developments.

Tuesday, May 4th @ 5:00 p.m. Eastern Time:
Domestic: 877-407-0792
International: 201-689-8263
Conference ID: 13717525
Webcast: http://public.viavid.com/index.php?id=143909

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-
approved neurostimulation technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
[email protected]
646-597-6989